Replimune Group, Inc. - Common Stock — 재무제표 (NASDAQ:REPL) | MetaTrader

전체 차트 열기 Full chart

뉴스

Biotech Investors Are Tuning Out the MAHA Chaos

What's Going On With Replimune Stock On Tuesday? - Replimune Group (NASDAQ:REPL)

Replimune stock collapses 64% following FDA rejection

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.63%

FDA Rejection Sparks Questions On Replimune Drug Approval Path - Replimune Group (NASDAQ:REPL)

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Replimune: Second CRL May Have Sealed RP1's Fate - It's Hard To See Positives (REPL)

FDA Review Looms As Replimune Faces Weak Technical Setup - Replimune Group (NASDAQ:REPL)

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer